Omnitarg And Herceptin Could Save Women Without Chemotherapy From Breast Cancer. Part 3 of 3

Omnitarg And Herceptin Could Save Women Without Chemotherapy From Breast Cancer – Part 3 of 3

Researchers countered negative side effects of the drugs, which included diarrhea, liver aim abnormalities, skin disorders and a low white blood cell count, by lowering patients’ dosages or administering additional medications to alleviate specific symptoms. Describing targeted therapies as a “HER2 blockade,” Spector said if bring in was not an issue, he would use all three drugs on HER2-positive breast cancer patients.

Discussing the high cost of treatment at the session, the researchers noted that spending more green on faster-acting, more effective treatments could save other treatment expenditures down the line. “I do think we need to be creative in the ways we run through this data to make things more affordable”. Because this studio was presented at a medical meeting, the findings should be viewed as preliminary until they are published in a peer-reviewed journal.

Parts: 1 2 3

Advertisements

2 thoughts on “Omnitarg And Herceptin Could Save Women Without Chemotherapy From Breast Cancer. Part 3 of 3

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s